Ignite Creation Date:
2024-05-06 @ 8:46 AM
Last Modification Date:
2024-10-26 @ 12:05 PM
Study NCT ID:
NCT02818309
Status:
UNKNOWN
Last Update Posted:
2016-06-29
First Post:
2016-06-21
Brief Title:
Lesogaberan in Chinese Patients With Refractory Reflux Symptoms
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Efficacy and Safety of Lesogaberan AZD3355 in Chinese Patients With Reflux Symptoms Refractory to Proton Pump Inhibitor Therapy a Randomized Placebo-controlled Trial
Status:
UNKNOWN
Status Verified Date:
2016-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Lesogaberan may be used in Chinese GERD patients with partial response to PPI
Detailed Description:
To test the efficacy and safety of lesogaberan
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None